BioCentury
ARTICLE | Company News

Isis Pharmaceuticals, U.S. Department of Defense, U.S. Department of Homeland Security infectious, diagnostic news

September 24, 2007 7:00 AM UTC

ISIS's Ibis Biosciences Inc. subsidiary received three contracts from DHS totaling $3.3 million to develop methods for identifying and characterizing undisclosed bacterial and viral agents. Ibis also ...